Prothena is a clinical-stage neuroscience company focused on the discovery and development of novel therapies.
Prothena has raised $172.4M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in December 2022.
Prothena's investors include Sofinnova Investments.
Prothena is headquartered in South San Francisco, United States.
Prothena is a clinical-stage neuroscience company focused on the discovery and development of novel therapies.
Prothena is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Prothena — Funding & Investors." VCBacked, December 14, 2022, https://www.vcbacked.co/company/prothena. Accessed September 30, 2026.
VCBacked. (2022). Prothena — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/prothena
{{cite web |title=Prothena — Funding & Investors |url=https://www.vcbacked.co/company/prothena |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated